ST诺泰 (688076)
Sinopep-Allsino Bio Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameJiangsu Nuotai Aosenuo Biopharmaceutical Co., Ltd.
Listing Date2021-05-20
Issue Price15.57RMB
Registered Capital31481.928110k RMB
Legal RepresentativeTong Ziquan
Registered AddressNo. 28 Linpu Road, Lianyungang Economic and Technological Development Zone, Jiangsu Province
IndustryChemical Pharmaceuticals
Main BusinessThe company is a biopharmaceutical enterprise focused on the integration of independent R&D and customized R&D and production (CDMO) for peptide drugs and small molecule chemical drugs.
Company ProfileNuotai Pharmaceutical was founded in 2004, primarily engaged in the research, development, and production of genetically engineered protein/peptide drugs and drugs for treating cardiovascular and cerebrovascular diseases. The company's main businesses cover innovative drug development (protein/peptide drugs, chemical drugs), R&D outsourcing services (custom peptide synthesis), and the industrial-scale production of Active Pharmaceutical Ingredients (APIs). After its development and expansion during the "First Five-Year" period, the company now possesses a Peptide Innovative Drug R&D Center located in Hangzhou, Zhejiang Province; a GMP-compliant Peptide API Production Base located in Haikou, Hainan Province; and an API Industrial Production Base compliant with European and US cGMP standards, located in Lianyungang, Jiangsu Province. The company has been successively recognized as a "Zhejiang Province Outstanding Technological Innovation Enterprise", "Hangzhou High-Tech Enterprise", and "National High-Tech Enterprise".
Nuotai Pharmaceutical possesses a continuously improving independent R&D system and a gradually strengthening scientific research team. The company has 185 employees, including over 60 R&D personnel. R&D technical staff with master's degrees or higher account for approximately 20% of the total workforce. The company's R&D Director and Technical Consultant are both US-educated PhDs who have achieved outstanding results in peptide drug design and R&D and possess extensive experience in peptide synthesis.
Stock Details
1. Key Indicators
- Total Shares(W): 31605.19
- Circulating A-Shares(W): 31605.19
- Earnings Per Share(RMB): 1.4200
- Net Assets Per Share(RMB): 9.8384
- Operating Revenue(W RMB): 152717.77
- Total Profit(W RMB): 49144.88
- **Net Profit Attributable to Parent(W RMB) **: 44454.24
- Net Profit Growth Rate(%): 26.92
- Weighted Return on Equity(%): 15.4100
- Operating Cash Flow Per Share(RMB): 1.2160
- Undistributed Profit Per Share(RMB): 3.1231
- Capital Reserve Per Share(RMB): 5.5502
2. Main Business
The main business covers:
- Peptide drugs and small molecule chemical drugs
- Strategic layout of oligonucleotide business
- Combination of independent R&D and custom R&D production
3. Company Basic Information
- Company Name: Jiangsu Nuopu Aosenuo Biopharmaceutical Co., Ltd.
- Listing Date: 2021-05-20
- Industry: Pharmaceutical Manufacturing
- Address: No. 28 Linpu Road, Lianyungang Economic and Technological Development Zone, Jiangsu Province
- Website: https://www.sinopep.cn/
- Company Profile: The company was established in 2015, transformed from Jiangsu Nuopu Pharmaceutical Technology Co., Ltd., and is mainly engaged in the research, development, and production of peptide drugs and small molecule chemical drugs.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| Data Missing | Data Missing | Data Missing | Data Missing | Data Missing |
5. Concept Sectors
- Data Missing
Remarks
- Data update date: 2025-10-30
- Data source: Public market information